Related Experiment Video
Updated: May 27, 2026

Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
Cardiometabolic risk variables in overweight and obese children: a worldwide comparison
Mariska van Vliet1, Martijn W Heymans, Inès A von Rosenstiel
1Department of Pediatrics, Slotervaart Hospital, Louwesweg 6, 1066 EC, Amsterdam, the Netherlands. Mariskavv@hotmail.com
Insights
Pediatric obesity is a global concern. This review found significant international variations in cardiometabolic risk factors among overweight children, highlighting differing health profiles worldwide.
Area of Science:
- Pediatric Endocrinology
- Global Public Health
- Cardiovascular Health
Background:
- Pediatric obesity rates are rising globally, often linked to cardiometabolic risk factors.
- Understanding international disparities in these risk factors among children is crucial.
Purpose of the Study:
- To review and compare cardiometabolic risk factors in overweight pediatric populations across different countries.
- To analyze prevalence and mean values of key metabolic syndrome components.
Main Methods:
- Systematic review of existing literature on overweight children.
- Selection of comparable cohorts based on age and sex.
- Comparison of prevalence and mean values for impaired glucose, high triglycerides, low HDL-cholesterol, and hypertension.
Main Results:
- Significant variations in cardiometabolic risk factor prevalence and means were observed among international cohorts.
- Children from Turkey, Hungary, Greece, Germany, Poland, and Dutch-Turkish populations showed the least favorable risk profiles.
- Children from Norway, Japan, Belgium, France, and the Dominican Republic exhibited the most favorable risk profiles.
Conclusions:
- There are substantial global differences in cardiometabolic risk profiles among overweight children.
- Findings should be interpreted cautiously due to cohort heterogeneity and limited outcome data.
- This review provides an estimation of international disparities in pediatric cardiometabolic risk.
Abstract:
The growing prevalence rate of pediatric obesity, which is frequently accompanied by several cardiometabolic risk factors, has become a serious global health issue. To date, little is known regarding differences for cardiometabolic risk factors (prevalence and means) in children from different countries. In the present review, we aimed to provide a review for the available evidence regarding cardiometabolic risk factors in overweight pediatric populations. We therefore provided information with respect to the prevalence of impaired fasting glucose/impaired glucose tolerance, high triglycerides, low HDL-cholesterol and hypertension (components of the metabolic syndrome) among cohorts from different countries. Moreover, we aimed to compare the means of glucose and lipid levels (triglycerides and HDL-cholesterol) and systolic/diastolic blood pressure values. After careful selection of articles describing cohorts with comparable age and sex, it was shown that both prevalence rates and mean values of cardiometabolic risk factors varied largely among cohorts of overweight children. After ranking for high/low means for each cardiometabolic risk parameter, Dutch-Turkish children and children from Turkey, Hungary, Greece, Germany and Poland were in the tertile with the most unfavorable risk factor profile overall. In contrast, cohorts from Norway, Japan, Belgium, France and the Dominican Republic were in the tertile with most favorable risk profile. These results should be taken with caution, given the heterogeneity of the relatively small, mostly clinical cohorts and the lack of information concerning the influence of the values of risk parameters on true cardiometabolic outcome measures in comparable cohorts. The results of our review present a fair estimation of the true differences between cardiometabolic risk profiles among pediatric cohorts worldwide, based on available literature.
Related Concept Videos
Obesity
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Type II Diabetes I: Introduction
Pharmacokinetics in Pediatric Patients: Drug Metabolism
